GlassScriptPhysician profile
Elham Khazaei
NPI 1740766633
$1,650.48
in general payments reported to CMS, 2019-2025
8 companies · $18.18 in 2025
The $18.18 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $807 · 2020: $247 · 2021: $198 · 2023: $259 · 2024: $121 · 2025: $18.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $398.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $851.66 | 2019-2021 | |
| Paragon 28, INC. | $259.29 | 2023 | Portfolio |
| Derma Sciences, INC. | $156.38 | 2019 | |
| Stryker Corporation | $149.07 | 2019-2025 | Dart-Fire |
| Teva Pharmaceuticals USA, INC. | $120.85 | 2024 | Austedo Xr |
| Kci USA, INC. | $42.18 | 2019 | |
| Abbvie INC. | $35.78 | 2021 | |
| Allergan, INC. | $35.27 | 2019-2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elham Khazaei listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.